These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 29034356)
21. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228 [TBL] [Abstract][Full Text] [Related]
22. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension. Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068 [TBL] [Abstract][Full Text] [Related]
23. Sacubitril/valsartan treatment relieved the progression of established pulmonary hypertension in rat model and its mechanism. Liu S; Wang Y; Lu S; Hu J; Zeng X; Liu W; Wang Y; Wang Z Life Sci; 2021 Feb; 266():118877. PubMed ID: 33310048 [TBL] [Abstract][Full Text] [Related]
24. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats. Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066 [TBL] [Abstract][Full Text] [Related]
25. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process. Angelini A; Castellani C; Ravara B; Franzin C; Pozzobon M; Tavano R; Libera LD; Papini E; Vettor R; De Coppi P; Thiene G; Vescovo G J Heart Lung Transplant; 2011 Nov; 30(11):1281-93. PubMed ID: 21989772 [TBL] [Abstract][Full Text] [Related]
27. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure. Adams KF Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833 [TBL] [Abstract][Full Text] [Related]
28. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension. Deng Y; Wu W; Guo S; Chen Y; Liu C; Gao X; Wei B Respir Res; 2017 Mar; 18(1):53. PubMed ID: 28340591 [TBL] [Abstract][Full Text] [Related]
29. Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen/hypoxia-induced pulmonary hypertension. Neto-Neves EM; Frump AL; Vayl A; Kline JA; Lahm T Physiol Rep; 2017 Oct; 5(19):. PubMed ID: 29038355 [TBL] [Abstract][Full Text] [Related]
30. Local and systemic renin-angiotensin system participates in cardiopulmonary-renal interactions in monocrotaline-induced pulmonary hypertension in the rat. Malikova E; Galkova K; Vavrinec P; Vavrincova-Yaghi D; Kmecova Z; Krenek P; Klimas J Mol Cell Biochem; 2016 Jul; 418(1-2):147-57. PubMed ID: 27344167 [TBL] [Abstract][Full Text] [Related]
31. Heart Rate Reduction Improves Right Ventricular Function and Fibrosis in Pulmonary Hypertension. Ishii R; Okumura K; Akazawa Y; Malhi M; Ebata R; Sun M; Fujioka T; Kato H; Honjo O; Kabir G; Kuebler WM; Connelly K; Maynes JT; Friedberg MK Am J Respir Cell Mol Biol; 2020 Dec; 63(6):843-855. PubMed ID: 32915674 [TBL] [Abstract][Full Text] [Related]
32. Reserve of Right Ventricular-Arterial Coupling in the Setting of Chronic Overload. Tello K; Dalmer A; Axmann J; Vanderpool R; Ghofrani HA; Naeije R; Roller F; Seeger W; Sommer N; Wilhelm J; Gall H; Richter MJ Circ Heart Fail; 2019 Jan; 12(1):e005512. PubMed ID: 30616360 [TBL] [Abstract][Full Text] [Related]
34. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. van Suylen RJ; Smits JF; Daemen MJ Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1423-8. PubMed ID: 9603118 [TBL] [Abstract][Full Text] [Related]
35. [Pulmonary artery denervation in pulmonary hypertension: physiological and clinical aspects]. Evlakhov VI; Poiasov IZ; Ovsiannikov VI Angiol Sosud Khir; 2021; 27(3):16-21. PubMed ID: 34528584 [TBL] [Abstract][Full Text] [Related]
36. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension. Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919 [TBL] [Abstract][Full Text] [Related]
37. Angiotensin Receptor-Neprilysin Inhibition Attenuates Right Ventricular Remodeling in Pulmonary Hypertension. Sharifi Kia D; Benza E; Bachman TN; Tushak C; Kim K; Simon MA J Am Heart Assoc; 2020 Jul; 9(13):e015708. PubMed ID: 32552157 [TBL] [Abstract][Full Text] [Related]
38. The effects of exercise on right ventricular contractility and right ventricular-arterial coupling in pulmonary hypertension. Spruijt OA; de Man FS; Groepenhoff H; Oosterveer F; Westerhof N; Vonk-Noordegraaf A; Bogaard HJ Am J Respir Crit Care Med; 2015 May; 191(9):1050-7. PubMed ID: 25710636 [TBL] [Abstract][Full Text] [Related]
39. Neurohormonal Modulation as a Therapeutic Target in Pulmonary Hypertension. García-Lunar I; Pereda D; Ibanez B; García-Álvarez A Cells; 2020 Nov; 9(11):. PubMed ID: 33266371 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms responsible for postmenopausal hypertension in a rat model: Roles of the renal sympathetic nervous system and the renin-angiotensin system. Maranon RO; Reckelhoff JF Physiol Rep; 2016 Feb; 4(2):. PubMed ID: 26811052 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]